Literature DB >> 1848667

The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains.

A D D'Andrea1, A Yoshimura, H Youssoufian, L I Zon, J W Koo, H F Lodish.   

Abstract

The erythropoietin (EPO) receptor (EPO-R), a member of a large cytokine receptor superfamily, has a 236-amino-acid cytoplasmic region which contains no obvious tyrosine kinase or other catalytic domain. In order to delineate the linear functional domains of the cytoplasmic tail, we generated truncated mutant cDNAs which were transfected into a murine interleukin-3-dependent cell line, Ba/F3, and the EPO-dependent growth characteristics of the stable transfectants were assayed. We identified two unique domains of the cytoplasmic tail. A membrane-proximal positive signal transduction domain of less than or equal to 103 amino acids, in a region highly similar to the interleukin-2 receptor beta chain, was sufficient for EPO-mediated signal transduction. A carboxy-terminal negative-control domain, a serine-rich region of approximately 40 amino acids, increased the EPO requirement for the Ba/F3 transfectants without altering EPO-R cell surface expression, affinity for EPO, receptor oligosaccharide processing, or receptor endocytosis. Truncation of this negative-control domain allowed the Ba/F3 transfectants to grow maximally in only 1 pM EPO, 1/10 the concentration required for growth of cells expressing the wild-type EPO-R. All truncated EPO-R mutants which retained the transmembrane region of the EPO-R polypeptide bound to the gp55 envelope protein of Friend spleen focus-forming virus. Only the functional EPO-R mutants were activated by the gp55, however, suggesting that gp55- and EPO-mediated signaling occur via a similar mechanism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848667      PMCID: PMC359883          DOI: 10.1128/mcb.11.4.1980-1987.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's.

Authors:  M Hatakeyama; M Tsudo; S Minamoto; T Kono; T Doi; T Miyata; M Miyasaka; T Taniguchi
Journal:  Science       Date:  1989-05-05       Impact factor: 47.728

Review 2.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.

Authors:  S K Hanks; A M Quinn; T Hunter
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

3.  Erythropoietin coming of age.

Authors:  A Erslev
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

4.  Specific binding of erythropoietin to spleen cells infected with the anemia strain of Friend virus.

Authors:  S B Krantz; E Goldwasser
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

5.  Expression cloning of the murine erythropoietin receptor.

Authors:  A D D'Andrea; H F Lodish; G G Wong
Journal:  Cell       Date:  1989-04-21       Impact factor: 41.582

6.  A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization.

Authors:  M Hatakeyama; H Mori; T Doi; T Taniguchi
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

7.  The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck.

Authors:  A Veillette; M A Bookman; E M Horak; J B Bolen
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

8.  Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo.

Authors:  R Palacios; M Steinmetz
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

9.  Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3.

Authors:  Y C Yang; A B Ciarletta; P A Temple; M P Chung; S Kovacic; J S Witek-Giannotti; A C Leary; R Kriz; R E Donahue; G G Wong
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

10.  The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes.

Authors:  C E Rudd; J M Trevillyan; J D Dasgupta; L L Wong; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

View more
  73 in total

Review 1.  Negative signaling in health and disease.

Authors:  K M Coggeshall
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein.

Authors:  L I Zon; J F Moreau; J W Koo; B Mathey-Prevot; A D D'Andrea
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

Review 3.  Erythropoietin receptor response circuits.

Authors:  Don M Wojchowski; Pradeep Sathyanarayana; Arvind Dev
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

4.  Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23.

Authors:  Xijie Yu; Omar A Ibrahimi; Regina Goetz; Fuming Zhang; Siobhan I Davis; Holly J Garringer; Robert J Linhardt; David M Ornitz; Moosa Mohammadi; Kenneth E White
Journal:  Endocrinology       Date:  2005-08-04       Impact factor: 4.736

5.  JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model.

Authors:  Thomas Mercher; Gerlinde Wernig; Sandra A Moore; Ross L Levine; Ting-Lei Gu; Stefan Fröhling; Dana Cullen; Roberto D Polakiewicz; Olivier A Bernard; Titus J Boggon; Benjamin H Lee; D Gary Gilliland
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

6.  Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response.

Authors:  F W Quelle; D Wang; T Nosaka; W E Thierfelder; D Stravopodis; Y Weinstein; J N Ihle
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

7.  A chimeric receptor/oncogene that can be regulated by a ligand in vitro and in vivo.

Authors:  K Okuda; A D'Andrea; R A Etten; J D Griffin
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

8.  Distinct regions of the human granulocyte-colony-stimulating factor receptor cytoplasmic domain are required for proliferation and gene induction.

Authors:  S F Ziegler; T A Bird; K K Morella; B Mosley; D P Gearing; H Baumann
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

9.  Functional regions of the mouse interleukin-10 receptor cytoplasmic domain.

Authors:  A S Ho; S H Wei; A L Mui; A Miyajima; K W Moore
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

10.  Erythropoietin-induced cellular differentiation requires prolongation of the G1 phase of the cell cycle.

Authors:  M Carroll; Y Zhu; A D D'Andrea
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.